Edition:
United Kingdom

People: Dermira Inc (DERM.OQ)

DERM.OQ on NASDAQ Stock Exchange Global Select Market

8.26USD
9:00pm BST
Change (% chg)

$-0.27 (-3.17%)
Prev Close
$8.53
Open
$8.56
Day's High
$8.56
Day's Low
$8.23
Volume
166,865
Avg. Vol
436,618
52-wk High
$15.47
52-wk Low
$6.00

Pena, Luis 

Mr. Luis C. Pena is Co-Founder, Chief Development Officer of the Company. He is a co-founder and has served as our Chief Development Officer since February 2016, after previously serving in various roles as our Executive Vice President of Product Development and Vice President of Product Development since June 2011. From November 2010 to June 2011, Mr. Peña served as a consultant to our company. Mr. Peña served as Vice President, Head of Global Prescription Development at Stiefel, a GSK company, from January 2010 to March 2011 and, from January 2007 to December 2009, Mr. Peña served as Senior Vice President Portfolio Planning and Management at Stiefel, prior to its acquisition by GlaxoSmithKline LLC. From 2005 to 2007, Mr. Peña served as Vice President of Portfolio Planning and Management of Connetics. From 2001 to 2005, Mr. Peña served as Vice President of Product Development of Nuvelo, Inc., a biopharmaceutical company. Previously, Mr. Peña served as Senior Director of Project Planning and Management for Theravance, Incorporated, a pharmaceutical company, and held various positions in manufacturing, research and development at Genentech. Mr. Peña currently serves as an advisor to the SPARK program for the Stanford University School of Medicine where he has been an advisor since 2012. Mr. Peña holds a B.S. in biochemistry from San Francisco State University.

Basic Compensation

Total Annual Compensation, USD 1,740,210
Restricted Stock Award, USD 779,298
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 2,519,500

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 20,000 569,528.00
Name Fiscal Year Total

Thomas Wiggans

4,371,180

Luis Pena

2,519,500

Andrew Guggenhime

2,360,030

Christopher Horan

2,358,110

Christopher Griffith

833,154

Lori Lyons-Williams

2,704,630
As Of  31 Dec 2018